Department of Biomedicine, Center of Biomedical Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Division of Molecular Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.
Int J Mol Sci. 2018 Jan 13;19(1):239. doi: 10.3390/ijms19010239.
Cell adhesion molecules (CAMs) are surface ligands, usually glycoproteins, which mediate cell-to-cell adhesion. They play a critical role in maintaining tissue integrity and mediating migration of cells, and some of them also act as viral receptors. It has been known that soluble forms of the viral receptors bind to the surface glycoproteins of the viruses and neutralize them, resulting in inhibition of the viral entry into cells. Nectin-1 is one of important CAMs belonging to immunoglobulin superfamily and herpesvirus entry mediator (HVEM) is a member of the tumor necrosis factor (TNF) receptor family. Both CAMs also act as alphaherpesvirus receptor. Transgenic mice expressing the soluble form of nectin-1 or HVEM showed almost complete resistance against the alphaherpesviruses. As another CAM, sialic acid-binding immunoglobulin-like lectins (Siglecs) that recognize sialic acids are also known as an immunoglobulin superfamily member. Siglecs play an important role in the regulation of immune cell functions in infectious diseases, inflammation, neurodegeneration, autoimmune diseases and cancer. Siglec-9 is one of Siglecs and capsular polysaccharide (CPS) of group B (GBS) binds to Siglec-9 on neutrophils, leading to suppress host immune response and provide a survival advantage to the pathogen. In addition, Siglec-9 also binds to tumor-produced mucins such as MUC1 to lead negative immunomodulation. Transgenic mice expressing the soluble form of Siglec-9 showed significant resistance against GBS infection and remarkable suppression of MUC1 expressing tumor proliferation. This review describes recent developments in the understanding of the potency of soluble forms of CAMs in the transgenic mice and discusses potential therapeutic interventions that may alter the outcomes of certain diseases.
细胞黏附分子(CAMs)是表面配体,通常为糖蛋白,介导细胞间黏附。它们在维持组织完整性和调节细胞迁移方面起着至关重要的作用,其中一些还充当病毒受体。已知病毒受体的可溶性形式与病毒的表面糖蛋白结合并中和它们,从而抑制病毒进入细胞。 nectin-1 是免疫球蛋白超家族中的重要 CAM 之一,而疱疹病毒进入介体(HVEM)是肿瘤坏死因子(TNF)受体家族的成员。这两种 CAM 也作为α疱疹病毒受体。表达 nectin-1 或 HVEM 的可溶性形式的转基因小鼠表现出对α疱疹病毒的几乎完全抗性。作为另一种 CAM,识别唾液酸的唾液酸结合免疫球蛋白样凝集素(Siglec)也被称为免疫球蛋白超家族成员。 Siglecs 在调节感染性疾病、炎症、神经退行性疾病、自身免疫性疾病和癌症中的免疫细胞功能方面发挥着重要作用。 Siglec-9 是 Siglecs 之一,B 组(GBS)荚膜多糖(CPS)与中性粒细胞上的 Siglec-9 结合,导致宿主免疫反应受到抑制,并为病原体提供生存优势。此外,Siglec-9 还与肿瘤产生的粘蛋白如 MUC1 结合,导致负性免疫调节。表达 Siglec-9 的可溶性形式的转基因小鼠对 GBS 感染表现出显著的抗性,并显著抑制 MUC1 表达的肿瘤增殖。这篇综述描述了对可溶性 CAM 形式在转基因小鼠中的作用的最新理解,并讨论了可能改变某些疾病结果的潜在治疗干预措施。